Perrigo Company plc Stock-Based Compensation
Perrigo Company plc (PRGO) reported Stock-Based Compensation of $21.20 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Perrigo Company plc share-based payment arrangement, noncash expense for the quarter ending 2026-06-27 was $6.80M, a 59.52% decline year-over-year.
- Perrigo Company plc share-based payment arrangement, noncash expense for the quarter ending 2026-03-28 was $14.40M, a 24.14% increase year-over-year.
- Perrigo Company plc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $13.00M, a 34.67% decline year-over-year.
- Perrigo Company plc share-based payment arrangement, noncash expense for the quarter ending 2025-09-27 was $13.20M, a 123.73% increase year-over-year.
- Perrigo Company plc share-based payment arrangement, noncash expense for fiscal 2025 was $54.60M, a 15.22% decline from fiscal 2024.
- Perrigo Company plc share-based payment arrangement, noncash expense for fiscal 2024 was $64.40M, a 6.40% decline from fiscal 2023.
- Perrigo Company plc share-based payment arrangement, noncash expense for fiscal 2023 was $68.80M, a 25.32% increase from fiscal 2022.
- Perrigo Company plc share-based payment arrangement, noncash expense for fiscal 2022 was $54.90M, a 8.65% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-27 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $21.20M 10-Q · filed 2026-08-05 | $34.20M derived: sum of 3 quarters · filed 2026-08-05 | $47.40M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-28 | $14.40M 10-Q · filed 2026-05-06 | $27.40M derived: sum of 2 quarters · filed 2026-05-06 | $40.60M derived: sum of 3 quarters · filed 2026-05-06 | $57.40M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.20M derived: sum of 2 quarters · filed 2026-02-26 | $43.00M derived: sum of 3 quarters · filed 2026-08-05 | $54.60M 10-K · filed 2026-02-26 | |||
| 2025-09-27 | $13.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $30.00M derived: sum of 2 quarters · filed 2026-08-05 | $41.60M 10-Q · filed 2025-11-05 | $61.50M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-28 | $16.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $28.40M 10-Q · filed 2026-08-05 | $48.30M derived: sum of 3 quarters · filed 2026-08-05 | $54.20M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-29 | $11.60M 10-Q · filed 2026-05-06 | $31.50M derived: sum of 2 quarters · filed 2026-05-06 | $37.40M derived: sum of 3 quarters · filed 2026-05-06 | $60.40M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $19.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.80M derived: sum of 2 quarters · filed 2026-02-26 | $48.80M derived: sum of 3 quarters · filed 2026-02-26 | $64.40M 10-K · filed 2026-02-26 | |||
| 2024-09-28 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $28.90M derived: sum of 2 quarters · filed 2025-11-05 | $44.50M 10-Q · filed 2025-11-05 | $55.10M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-29 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $38.60M 10-Q · filed 2025-08-06 | $49.20M derived: sum of 3 quarters · filed 2026-02-26 | $63.90M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-30 | $15.60M 10-Q · filed 2025-05-07 | $26.20M derived: sum of 2 quarters · filed 2026-02-26 | $40.90M derived: sum of 3 quarters · filed 2026-02-26 | $59.50M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.30M derived: sum of 2 quarters · filed 2026-02-26 | $43.90M derived: sum of 3 quarters · filed 2026-02-26 | $68.80M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $14.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $33.30M derived: sum of 2 quarters · filed 2024-11-06 | $58.20M 10-Q · filed 2024-11-06 | $66.40M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-07-01 | $18.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $43.50M 10-Q · filed 2024-08-02 | $51.70M derived: sum of 3 quarters · filed 2025-02-28 | $61.10M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-04-01 | $24.90M 10-Q · filed 2024-05-07 | $33.10M derived: sum of 2 quarters · filed 2025-02-28 | $42.50M derived: sum of 3 quarters · filed 2025-02-28 | $53.50M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $17.60M derived: sum of 2 quarters · filed 2025-02-28 | $28.60M derived: sum of 3 quarters · filed 2025-02-28 | $54.90M 10-K · filed 2025-02-28 | |||
| 2022-10-01 | $9.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $20.40M derived: sum of 2 quarters · filed 2023-11-07 | $46.70M 10-Q · filed 2023-11-07 | $56.60M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-07-02 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $37.30M 10-Q · filed 2023-08-08 | $47.20M derived: sum of 3 quarters · filed 2024-02-27 | $58.30M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-04-02 | $26.30M 10-Q · filed 2023-05-09 | $36.20M derived: sum of 2 quarters · filed 2024-02-27 | $47.30M derived: sum of 3 quarters · filed 2024-02-27 | $61.40M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $21.00M derived: sum of 2 quarters · filed 2024-02-27 | $35.10M derived: sum of 3 quarters · filed 2024-02-27 | $60.10M 10-K · filed 2024-02-27 | |||
| 2021-10-02 | $11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $25.20M derived: sum of 2 quarters · filed 2022-11-08 | $50.20M 10-Q · filed 2022-11-08 | $64.80M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-07-03 | $14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $39.10M 10-Q · filed 2022-08-09 | $53.70M derived: sum of 3 quarters · filed 2023-02-28 | $67.90M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-04-03 | $25.00M 10-Q · filed 2022-05-11 | $39.60M derived: sum of 2 quarters · filed 2023-02-28 | $53.80M derived: sum of 3 quarters · filed 2023-02-28 | $67.30M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $28.80M derived: sum of 2 quarters · filed 2023-02-28 | $42.30M derived: sum of 3 quarters · filed 2023-02-28 | $58.50M 10-K · filed 2023-02-28 | |||
| 2020-09-26 | $14.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $27.70M derived: sum of 2 quarters · filed 2021-11-12 | $43.90M 10-Q · filed 2021-11-12 | $55.20M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-27 | $13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $29.70M 10-Q · filed 2021-08-11 | $41.00M derived: sum of 3 quarters · filed 2022-03-01 | $53.90M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-28 | $16.20M 10-Q · filed 2021-05-12 | $27.50M derived: sum of 2 quarters · filed 2022-03-01 | $40.40M derived: sum of 3 quarters · filed 2022-03-01 | $56.00M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $24.20M derived: sum of 2 quarters · filed 2022-03-01 | $39.80M derived: sum of 3 quarters · filed 2022-03-01 | $52.20M 10-K · filed 2022-03-01 | |||
| 2019-09-28 | $12.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $28.50M derived: sum of 2 quarters · filed 2020-11-05 | $40.90M 10-Q · filed 2020-11-05 | $52.00M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-29 | $15.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $28.00M 10-Q · filed 2020-08-05 | $39.10M derived: sum of 3 quarters · filed 2021-03-01 | $43.40M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-30 | $12.40M 10-Q · filed 2020-05-05 | $23.50M derived: sum of 2 quarters · filed 2021-03-01 | $27.80M derived: sum of 3 quarters · filed 2021-03-01 | $37.40M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $15.40M derived: sum of 2 quarters · filed 2021-03-01 | $25.00M derived: sum of 3 quarters · filed 2021-03-01 | $37.70M 10-K · filed 2021-03-01 | |||
| 2018-09-29 | $4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $13.90M derived: sum of 2 quarters · filed 2019-11-06 | $26.60M 10-Q · filed 2019-11-06 | $42.30M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-06-30 | $9.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $22.30M 10-Q · filed 2019-08-08 | $38.00M derived: sum of 3 quarters · filed 2020-02-27 | $51.30M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-03-31 | $12.70M 10-Q · filed 2019-05-09 | $28.40M derived: sum of 2 quarters · filed 2020-02-27 | $41.70M derived: sum of 3 quarters · filed 2020-02-27 | $50.40M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2017-12-31 | $15.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $29.00M derived: sum of 2 quarters · filed 2020-02-27 | $37.70M derived: sum of 3 quarters · filed 2020-02-27 | $43.80M 10-K · filed 2020-02-27 | |||
| 2017-09-30 | $13.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $22.00M derived: sum of 2 quarters · filed 2018-11-08 | $28.10M 10-Q · filed 2018-11-08 | $35.80M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-07-01 | $8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $14.80M 10-Q · filed 2018-08-09 | $22.50M derived: sum of 3 quarters · filed 2019-02-27 | $28.20M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-04-01 | $6.10M 10-Q · filed 2018-05-08 | $13.80M derived: sum of 2 quarters · filed 2019-02-27 | $19.50M derived: sum of 3 quarters · filed 2019-02-27 | $13.30M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $13.40M derived: sum of 2 quarters · filed 2019-02-27 | $7.20M derived: sum of 3 quarters · filed 2019-02-27 | $23.00M 10-K · filed 2019-02-27 | |||
| 2016-10-01 | $5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$500.00K derived: sum of 2 quarters · filed 2017-11-09 | $15.30M 10-Q · filed 2017-11-09 | $16.10M 10-Q · filed 2016-11-10 | $23.80M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-07-02 | -$6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $9.60M 10-Q · filed 2017-08-10 | $7.60M 10-Q · filed 2016-08-10 | $18.10M derived: sum of 3 quarters · filed 2018-03-01 | $32.40M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-04-02 | $15.80M 10-Q · filed 2017-05-30 | $13.80M 10-Q · filed 2016-05-16 | $24.30M derived: sum of 2 quarters · filed 2018-03-01 | $38.60M derived: sum of 3 quarters · filed 2018-03-01 | $46.60M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $8.50M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $22.80M 10-K · filed 2018-03-01 | $24.80M 10-KT · filed 2016-02-25 | $30.80M derived: sum of 3 quarters · filed 2018-03-01 | $38.30M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-09-26 | $14.30M 10-Q · filed 2015-11-02 | $22.30M derived: sum of 2 quarters · filed 2017-05-22 | $29.70M 10-Q/A · filed 2017-05-23 | $37.20M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2015-06-27 | $8.00M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $15.50M 10-Q/A · filed 2017-05-22 | $22.90M derived: sum of 3 quarters · filed 2017-05-22 | $31.60M 10-K · filed 2018-03-01 | |||
| 2015-03-28 | $7.50M 10-Q/A · filed 2017-05-22 | $14.90M derived: sum of 2 quarters · filed 2017-05-22 | $23.70M 10-Q · filed 2015-04-29 | $29.80M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-12-27 | $7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $16.20M 10-Q · filed 2015-02-05 | $22.30M derived: sum of 3 quarters · filed 2017-05-22 | $27.20M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-09-27 | $8.80M 10-Q · filed 2015-11-02 | $14.90M derived: sum of 2 quarters · filed 2017-05-22 | $19.80M derived: sum of 3 quarters · filed 2017-05-22 | $27.50M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-06-28 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $11.00M derived: sum of 2 quarters · filed 2017-05-22 | $18.70M derived: sum of 3 quarters · filed 2017-05-22 | $24.60M 10-K · filed 2017-05-22 | |||
| 2014-03-29 | $4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $12.60M derived: sum of 2 quarters · filed 2015-04-29 | $18.50M 10-Q · filed 2015-04-29 | $22.90M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-28 | $7.70M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $13.60M 10-Q · filed 2015-02-05 | $18.00M derived: sum of 3 quarters · filed 2016-02-25 | $22.60M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-09-28 | $5.90M 8-K · filed 2014-11-20 | $10.30M derived: sum of 2 quarters · filed 2016-02-25 | $14.90M derived: sum of 3 quarters · filed 2016-02-25 | ||||
| 2013-06-29 | $4.40M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $9.00M derived: sum of 2 quarters · filed 2016-02-25 | $18.40M 10-KT · filed 2016-02-25 | ||||
| 2013-03-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $14.00M 10-Q · filed 2014-05-07 | |||||
| 2012-12-29 | $9.40M 10-Q · filed 2014-02-06 | ||||||
| 2012-06-30 | $19.00M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |